<p><strong>Lizobon</strong> is a premium product from Bongyn Bioscience Pvt Ltd, formulated to treat bacterial infections resistant to other antibiotics. Each tablet contains <strong>Linezolid IP 600 mg</strong>, a synthetic antibiotic from the oxazolidinone class, which inhibits bacterial protein synthesis, stopping their growth and spread. Lizobon is indicated for treating pneumonia (community-acquired and hospital-acquired), skin and soft tissue infections, and resistant bacterial infections like MRSA and VRE. It is generally well-tolerated but may cause common side effects like nausea, diarrhea, or headache. Patients should strictly follow prescribed doses and avoid skipping or stopping treatment early. Always inform your doctor about your medical history and ongoing medications before starting Lizobon. For any adverse effects or concerns, consult your healthcare provider. Lizobon is a quality product from Bongyn Bioscience Pvt Ltd. </p>